Live Breaking News & Updates on Pharmaceuticals nec trbc level 5

Stay informed with the latest breaking news from Pharmaceuticals nec trbc level 5 on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Pharmaceuticals nec trbc level 5 and stay connected to the pulse of your community

Bayer reaches $6.9 mln settlement with New York over Roundup weedkiller

Bayer AG has reached a $6.9 million settlement with New York for allegedly making false and misleading claims regarding the safety of Roundup weedkillers, the state's Attorney General Letitia James said on Thursday.

New-york , United-states , Letitia-james , Jonathan-stempel , Thomson-reuters-trust-principles , Monsanto , Bayer-ag , Reuters , Attorney-general-letitia-james , Thomson-reuters-trust , Bayer , New-york-roundup

AstraZeneca to stop developing Crohn's disease drug

British drugmaker AstraZeneca said on Thursday it would stop developing its drug brazikumab to treat inflammatory bowel diseases, including Crohn's disease and ulcerative colitis.

Bengaluru , Karnataka , India , United-kingdom , British , Yadarisa-shabong , Savio-dsouza , Abbvie-skyrizi , Astrazeneca , Allergan , Reuters , Thomson-reuters-trust-principles

UPDATE 1-Agrichemicals company Syngenta reports higher Q1 sales and profit

Swiss agrichemicals group Syngenta on Thursday reported higher first-quarter sales and profit, having passed on higher costs to farmers buying its seeds and sprays.

Shanghai , China , United-states , New-york , Switzerland , Zurich , Züsz , Germany , London , City-of , United-kingdom , Swiss

GSK to buy Canada's Bellus Health for $2 bln

GSK Plc will buy Canada-based late-stage biopharma firm Bellus Health Inc in an all-cash deal for $2 billion, the companies said in a joint statement on Tuesday. (Reporting by Aby Jose Koilparambil in Bengaluru; Editing by Savio D'Souza)

Canada , Bengaluru , Karnataka , India , Jose-koilparambil , Savio-dsouza , Thomson-reuters-trust-principles , Reuters , Bellus-health-inc , Aby-jose-koilparambil , Saviod-souza , Thomson-reuters-trust

Pfizer RSV vaccine 82% effective vs severe infection in infants, final data shows (April 5)

(This April 5 story has been refiled to add a missing word in paragraph 3)

United-states , Bengaluru , Karnataka , India , Bhanvi-satija , Caroline-humer , Pfizer , Reuters , Pfizer-inc , Drug-administration , Astrazeneca , Thomson-reuters-trust-principles

CORRECTED-UPDATE 1-Nigeria receives 2 million doses of J&J COVID vaccine from EU countries

Nigeria has received 2 million doses of the Johnson & Johnson COVID-19 vaccine from Finland, Greece and Slovenia, with more EU donations set to arrive in the coming weeks, government officials said on Monday.

Finland , Nigeria , Abuja , Abuja-federal-capital-territory , Greece , Slovenia , Nigerians , Faisal-shuaib , Mark-porter , Jon-boyle , Julia-payne , Camillus-eboh

UPDATE 1-Americas may be left behind in access to new COVID treatments, says PAHO

The Americas could be left behind as new treatments for COVID-19 are developed and approved, the Pan American Health Organization (PAHO) said on Wednesday, urging countries and companies to work together to ensure access across the region.

Ecuador , Paraguay , Uruguay , United-states , Canada , Bogota , Cundinamarca , Colombia , America , Rosalba-obrien , Carissa-etienne , Mark-porter

ANALYSIS-Omicron is a wake-up call for COVID-19 vaccine developers

Arrival of the highly-mutated Omicron variant is a wake-up call to develop vaccines less susceptible to the rapid changes of the coronavirus, leading virologists and immunologists told Reuters.

Germany , New-york , United-states , United-kingdom , New-jersey , China , France , Chicago , Illinois , London , City-of , French

European shares hit over 1-week highs as Omicron worries fade

European stocks rose on Tuesday to their highest in more than a week, with technology shares witnessing a rebound, as worries about the Omicron coronavirus variant ebbed, while miners jumped after China eased its monetary policy.

China , Bengaluru , Karnataka , India , France , Greece , French , Anisha-sircar , Thomson-reuters-trust-principles , Reuters , Thomson-reuters-trust , Europe

INSIGHT-COVID shots are finally arriving, but Africa can't get them all into arms

* Lack of funds, staff and community outreach hamper campaigns

Namibia , South-sudan , Kenya , India , Mali , Narok , Rift-valley , Talek , Congo , Cameroon , Nairobi , Nairobi-area